ALMS as of Oct 31 · 23:41 ET
ALMSNasdaqPharmaceutical Preparations

Alumis Inc. · Brief

Next report

11 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
0 of 7≥ implied
avg implied
±23.3%
avg realized
±6.2%
Mar 19 '25—▼−18.31%—
May 14 '25±33.3%▲+18.63%×0.56
Aug 13 '25±31.0%▼−0.68%×0.02
Q3 FY25±27.2%▲+4.55%×0.17
Jan 9 '26±10.1%▲+7.59%×0.75
Q1 FY26±20.4%▼−1.26%×0.06
May 14 '26±16.1%▼−7.15%×0.44
Q2 FY26±25.3%▲+3.69%×0.15
quarterimplied−35%0+35%realized×
Q2 FY26±25.3%▲+3.69%×0.15
May '26±16.1%▼−7.15%×0.44
Q1 FY26±20.4%▼−1.26%×0.06
Jan '26±10.1%▲+7.59%×0.75
Q3 FY25±27.2%▲+4.55%×0.17
Aug '25±31.0%▼−0.68%×0.02
2 older reports
May '25±33.3%▲+18.63%×0.56
Mar '25—▼−18.31%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2 of 4

3disclosed supplier and customer ties named in SEC filingsSEC filings
203managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

3tracked funds holding ALMSN-PORT · Aug 31 '26
5 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ALMS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±16.7% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.